Safety in Advanced Therapies – Malignancy
Dr Diana Rubel presents on Safety in Advanced Therapies – Malignancy.
Dr Diana Rubel presents on Safety in Advanced Therapies – Malignancy.
Join Professor Chris Blyth as he brings the dermatology community up to speed with the infection, the COVID-19 vaccination program, including available agents, their differences (clinically and mechanism of action), and much more!
Join A/Prof David Orchard, A/Prof John Su and Dr Lena Ly as they present current best practices and challenges in the management of atopic dermatitis in the paediatric and adolescent population.
Join Dr Gayle Ross, Dr Ryan De Cruz and Dr Lena Ly as they present the current practice as well as future management options.
In this session, Dr Satveer Mahil provides an update on the current state of play with regard to the global pandemic in the dermatology patient population, based on the PsoProtect and PsoProtectMe registries’ data.
Professor Connie Katelaris speaks on Signalling Pathways Atopic Dermatitis in this session.
A/Prof Peter Foley and Prof Stephen Hall speak on their experience of co-managing patients.
A/Prof David Orchard speaks on biologic advancements in paediatric psoriasis, followed by A/Prof Peter Foley and A/Prof Chris Baker discussing highlights from the 9th International Congress- Psoriasis: From Gene to Clinic 2021.
Dr John Frew presents on IL-17 pathogenesis of Psoriasis. The session covers current practice and future management options on the near or far horizon.
Join Dr Jonathan Darby for a Safety in Advanced Therapies – infection masterclass.